Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IYH vs. RXL: which is better?

Bottom line

IYH vs RXL: the short answer

IYH (iShares U.S. Healthcare ETF) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 73% by weight.

IYH is cheaper at 0.37% vs 0.95% — a difference of $58 a year per $10,000 invested.

Over five years, RXL returned +7.2% a year vs +7.0% for IYH.

Updated Nov 19, 2026

IYH vs RXL side by side

IYHRXL
TypeETFETF
Fund familyiSharesProShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.95%
Annual cost per $10k$37$95
10-yr cost on $10k (prospectus)$468$1,305
Max front loadNoneNone
12b-1 fee0%—
1-yr return+13.1%+19.7%
5-yr return (annualized)+7.0%+7.2%
10-yr return (annualized)+9.4%+12.6%
Best quarter+15.3%+29.7%
Worst quarter−12.7%−28.9%
Net assets (fund)$3.6B$72.1M
Number of holdings10370
Portfolio turnover3%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIYHRXLDifference
2025+13.1%+19.7%−6.6%
2024+3.1%−2.7%+5.7%
2023+2.1%−3.2%+5.2%
2022−4.4%−15.1%+10.7%
2021+23.4%+47.8%−24.4%
2020+15.5%+19.2%−3.8%
2019+20.8%+38.9%−18.1%
2018+5.9%+5.4%+0.5%
2017+22.3%+46.0%−23.7%
2016−2.8%−8.9%+6.1%

Source: Fund prospectus bar charts

Holdings overlap

18 of IYH's top 25 holdings also appear in RXL's top 25.

Shared top holdings
HoldingIYHRXL
Eli Lilly And Company15.11%12.67%
Johnson & Johnson10.17%7.86%
Abbvie Inc.7.32%5.57%
Unitedhealth Group Incorporated6.16%4.98%
Merck & Co., Inc.5.31%4.26%
Thermo Fisher Scientific Incorporated3.52%2.68%
Amgen Inc.3.42%2.62%
Abbott Laboratories3.02%2.15%
Gilead Sciences, Inc.2.66%2.41%
Pfizer Inc.2.35%2.15%
Bristol-myers Squibb Company2.20%1.68%
Intuitive Surgical, Inc.2.05%2.18%
Danaher Corporation2.03%1.66%
Vertex Pharmaceuticals Incorporated2.00%1.64%
Stryker Corporation1.86%1.52%

Source: SEC Form N-PORT

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

FAQ

What is the difference between IYH and RXL?
IYH (iShares U.S. Healthcare ETF) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 73% by weight. IYH is cheaper at 0.37% vs 0.95% — a difference of $58 a year per $10,000 invested.
Which is cheaper, IYH or RXL?
IYH has the lower expense ratio (0.37%).
Should I own both IYH and RXL?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.